Calcaneal Spur
Conditions
Brief summary
PURPOSE: To compare the effect of Extracorporeal shock wave therapy and high-power LASER therapy for the treatment of patients with calcaneal spur Background: Calcaneal spur is a common musculoskeletal disorder of the foot that affect the quality-of-life Conservative treatment modalities include, cold application, platelet-rich plasma therapy (PRP), shoe modification, therapeutic ultrasound, extracorporeal shock wave therapy (ESWT), laser therapy (LLLT) are commonly used in the treatment of calcaneal spur. HYPOTHESES: There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on pain intensity in patients with calcaneal spur There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on function in patients with calcaneal spur. There will be difference between Extracorporeal shock wave therapy and High- power LASER therapy on the size of calcaneal spur in patients with calcaneal spur. RESEARCH QUESTION: Is there any difference between the effect of Extracorporeal shock wave therapy and High-power LASER on calcaneal spur?
Interventions
DRUGPlatelet rich plasma
Platelet-rich plasma for the heel
OTHERHigh power LASER
High power LASER sessions for the heel
OTHERShockwave therapy
Shockwave therapy sessions for the heel
OTHERIce application
Ice application for the heel
OTHERSham LASER
Sham LASER for the heel
Sponsors
Suez University
Badr University
Helwan University
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
25 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
diagnosed with calcaneal spur based on clinical examination and radiological findings.
Exclusion criteria
were as follows: acute trauma to the foot, history of fracture or surgery, lower extremity neurological deficit, polyneuropathy, radicular pain, autoimmune diseases tumor, thrombosis, soft tissue or bone infection, or skin disorder.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain Visual Analog Scale | Baseline and after one month | It is a self reported outcome which is a 10 cm line with zero at one end indicating no pain and 10 at the other end indicating maximum pain. Patient will be asked to mark the current pain on the scale and the distance from the starting point (0) will be measured |
| foot function index. | Baseline and after one month | measure the impact of foot pathology on function in terms of pain, disability and activity restriction. it is a self-administered index |
| calcaneal Spur length | Baseline and after one month | Spur length will be measured by MRI |
Countries
Egypt
Contacts
Primary ContactMina Wahba, PhD
Backup ContactDoha Hamed, PhD
Outcome results
None listed